SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-018766
Filing Date
2024-02-22
Accepted
2024-02-22 16:10:48
Documents
101
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K dvax-20231231.htm   iXBRL 10-K 3677015
2 EX-21.1 dvax-ex21_1.htm EX-21.1 2994
3 EX-23.1 dvax-ex23_1.htm EX-23.1 7680
4 EX-31.1 dvax-ex31_1.htm EX-31.1 24013
5 EX-31.2 dvax-ex31_2.htm EX-31.2 24006
6 EX-32.1 dvax-ex32_1.htm EX-32.1 8442
7 EX-32.2 dvax-ex32_2.htm EX-32.2 8392
8 EX-97.1 dvax-ex97_1.htm EX-97.1 55062
9 GRAPHIC img25882306_0.jpg GRAPHIC 278743
  Complete submission text file 0000950170-24-018766.txt   16048147

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT dvax-20231231.xsd EX-101.SCH 2258135
103 EXTRACTED XBRL INSTANCE DOCUMENT dvax-20231231_htm.xml XML 3025942
Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34207 | Film No.: 24664824
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)